I-Tech AB

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: SE0011167725
SEK
66.60
1.6 (2.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Underperformed the market in the last 1 year

  • Even though the market (OMX Stockholm 30) has generated returns of 25.50% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -31.76% returns
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

SEK 756 Million (Micro Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.38%

stock-summary
Debt Equity

-0.85

stock-summary
Return on Equity

19.03%

stock-summary
Price to Book

4.33

Revenue and Profits:
Net Sales:
53 Million
(Quarterly Results - Mar 2026)
Net Profit:
15 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
52.75%
0%
52.75%
6 Months
0.91%
0%
0.91%
1 Year
-31.76%
0%
-31.76%
2 Years
36.2%
0%
36.2%
3 Years
-13.51%
0%
-13.51%
4 Years
83.98%
0%
83.98%
5 Years
-6.98%
0%
-6.98%

I-Tech AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
26.06%
EBIT Growth (5y)
64.00%
EBIT to Interest (avg)
18.87
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
1.03
Tax Ratio
20.68%
Dividend Payout Ratio
45.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
42.97%
ROE (avg)
10.94%

Valuation key factors

Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
3.59
EV to EBIT
10.72
EV to EBITDA
9.09
EV to Capital Employed
18.23
EV to Sales
2.84
PEG Ratio
NA
Dividend Yield
1.66%
ROCE (Latest)
170.01%
ROE (Latest)
19.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 36.18% vs -5.61% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 140.62% vs -31.91% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.70",
          "val2": "38.70",
          "chgp": "36.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.50",
          "val2": "10.20",
          "chgp": "100.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.40",
          "val2": "6.40",
          "chgp": "140.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "352.30%",
          "val2": "212.50%",
          "chgp": "13.98%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -6.35% vs 48.47% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -14.87% vs 93.07% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.10",
          "val2": "179.50",
          "chgp": "-6.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.70",
          "val2": "52.10",
          "chgp": "-4.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "33.20",
          "val2": "39.00",
          "chgp": "-14.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "265.20%",
          "val2": "262.20%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
52.70
38.70
36.18%
Operating Profit (PBDIT) excl Other Income
20.50
10.20
100.98%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
15.40
6.40
140.62%
Operating Profit Margin (Excl OI)
352.30%
212.50%
13.98%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 36.18% vs -5.61% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 140.62% vs -31.91% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
168.10
179.50
-6.35%
Operating Profit (PBDIT) excl Other Income
49.70
52.10
-4.61%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
33.20
39.00
-14.87%
Operating Profit Margin (Excl OI)
265.20%
262.20%
0.30%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -6.35% vs 48.47% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -14.87% vs 93.07% in Dec 2024

stock-summaryCompany CV
About I-Tech AB stock-summary
stock-summary
I-Tech AB
Chemicals & Petrochemicals
I-Tech AB is a Sweden-based company that operates as a marine paint and antifouling technology company. The Company offers antifouling agents and binding technologies, such as metallic and organic binding/carrier/release systems for medetomidine through which the substance can be released in a low and constant concentration from the paint formulation. The Company is developing Selektope- marine biocide to be used in marine paint prohibiting growth on ship and boat hulls. The product has received regulatory approvals in Japan and Korea and is under registration in Europe and China.
Company Coordinates stock-summary
Company Details
C/o Astra Zeneca AB, Pepparedsleden 1 , MOLNDAL None : 431 83
stock-summary
Tel: 46 31 788056046 73 9103708
stock-summary
Registrar Details